Table 1.
Preoperative and surgical features of 1943 patients undergoing elective urological procedures in 28 different Italian centres between the 24th of February and the 30th of March 2020
| Preoperative features | |
|---|---|
| Age, median (IQR) | 67 (58–74) |
| BMI, median (IQR) | 25.6 (23.5–27.7) |
| ASA score, median (IQR) | 2 (2–3) |
| Charlson Comorbidity Index, median (IQR) | 3 (1–4) |
| Barthel Index, median (IQR) | 100 (96–100) |
| Race or ethnicity, n. (%) White/Caucasian Hispanic Black/African American Asian |
1908 (98.2%) 2 (0.1%) 23 (1.2%) 10 (0.5%) |
| Provenance from ‘COVID-19 red zones’, n. (%) No Yes |
1399 (72%) 544 (28%) |
| Risk hospital area, n (%) Low Medium High |
166 (8.5%) 891 (45.9%) 866 (44.6%) |
| History of previous neoplasm, n. (%) No Yes |
638 (32,8%) 1305 (67.2%) |
| Dry cough in the 60 days prior to hospitalization, n. (%) No Yes |
1889 (97.2%) 54 (2.8%) |
| Fever for more than 3 days in the 60 days prior to hospitalization, n. (%) No Yes |
1910 (98.3%) 33 (1.7%) |
| IgM testing in the 60 days prior to hospitalization, n. (%) No Yes |
1844 (94.9%) 99 (5.1%) |
| IgG testing in the 60 days prior to hospitalization, n. (%) No Yes |
1832 (94.3%) 111 (5.7%) |
| Nasopharyngeal swab in the 60 days prior to hospitalization, n. (%) No Yes |
1937 (99.7%) 6 (0.3%) |
| Nasopharyngeal swab at hospitalization, n. (%) No Yes |
1805 (92.9%) 138 (7.1%) |
| Preoperative haemoglobin (mg/dL), median (IQR) | 13.9 (12.7–15.1) |
| Preoperative creatinine serum level (mg/dL), median (IQR) | 0.96 (0.8–1.16) |
| Surgical indication, n (%) Benign condition Malignant condition |
676 (34.8%) 1267 (65.2%) |
n – number; IQR- interquartile range; BMI – body mass index; ASA – American Society of Anesthesiologists; IgM – immunoglobulin-M; IgG – immunoglobulin-G